![Todd C. Zankel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
George Davis | M | 53 | 20 ans | |
Elaine Heron | M | 76 | 22 ans | |
Brian Mueller | M | 50 | 22 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Kim Tsuchimoto | F | 61 |
Raptor Pharmaceuticals Corp.
![]() Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 18 ans |
Grant W. Denison | M | - | - | |
Pierre LaPalme | M | 83 | 12 ans | |
Mark Wood | M | 57 | 9 ans | |
Fredric D. Price | M | 78 | 4 ans | |
Louis C. Drapeau | M | 79 | 3 ans | |
Sandra Shpilberg | F | 48 | 9 ans | |
Christopher Starr | M | 71 | 9 ans | |
Joshua Grass | M | - | 14 ans | |
Raymond Anderson | M | 82 | 4 ans | |
Robert A. Heft | M | 69 | 3 ans | |
Patrice Rioux | M | 73 |
Raptor Pharmaceuticals Corp.
![]() Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 5 ans |
Steven Jungles | M | 58 | - | |
John Urquhart | M | - | - | |
Amy Lea Waterhouse | F | - | - | |
Karl Cahill | M | 51 |
Raptor Pharmaceuticals Corp.
![]() Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | - |
Vimal Srivastava | M | 58 | 2 ans | |
Alejandro Dorenbaum | M | 64 | 7 ans | |
Dan Oppenheimer | M | - | 14 ans | |
John Ditton | M | 60 | 2 ans | |
Stuart J. Swiedler | M | 68 | - | |
Matt Patterson | M | 52 | 6 ans | |
Craig Johnson | M | 62 |
Raptor Pharmaceuticals Corp.
![]() Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 1 ans |
Franz L. Cristiani | M | 83 | - | |
Robert Baffi | M | 68 | 20 ans | |
Vijay Samant | M | 77 | 2 ans | |
Erich Sager | M | 66 | 9 ans | |
Emil Kakkis | M | 63 | 11 ans | |
John C. Klock | M | 79 | - | |
Ansbert Gadicke | M | 66 | 4 ans | |
David Scott Geyer | M | 65 | 1 ans | |
Jeffrey Cooper | M | 68 | 9 ans | |
Min MIn Qin | M | 66 | 7 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 36 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Todd C. Zankel
- Réseau Personnel